Editor Profile

Michael R. McClung, MD, FACP, FACE

Contributing Editor

About the NEJM Journal Watch Women’s Health Board

Michael R. McClung, MD, FACP, FACE, is the Founding Director of the Oregon Osteoporosis Center in Portland and an internationally recognized clinician, researcher, and educator in osteoporosis and metabolic bone diseases. Dr. McClung was a member of the WHO Fracture Risk Task Force that led to the development of the FRAX tool. He has served on the FDA’s Endocrinology and Metabolism Advisory Committee and participated in the development of evidence-based guidelines for the treatment of osteoporosis for several national and international societies. He has been writing for NEJM Journal Watch Women's Health since 2016.

Disclosures

Consultant / Advisory board

Amgen; Merck; Radius Health

Speaker's bureau

Amgen

Editorial boards

Journal of Bone and Mineral Research; Menopause; Osteoporosis International

Leadership positions in professional societies

North American Menopause Society and International Osteoporosis Foundation (Board Member)

Summaries by Michael McClung